Introduction
Brain Tumor Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumors. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care.
Key Features
- - Discusses how to overcome the blood-brain barrier using advanced delivery methods.
- - Explains how to improve drug penetration and specificity with nano and polymer-based systems.
- - Explores new therapies through immunotherapy, gene therapy, and personalised medicine.
- - Outlines preclinical models and identifies biomarkers to support clinical success.
- - Details regulatory-aligned clinical trial strategies for faster translation.
Target Readership:
Researchers, clinicians, pharma developers, and graduate students in neuro-oncology, molecular pharmacology, and oncology-focused biotechnology.